Inventor

LEGGETT DAVID

US9 patents

⚠️ This page may combine multiple inventors who share the name “LEGGETT DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOSTON BIOMEDICAL INC

5 patents

US9834532B2Dec 5, 2017

Stat3 pathway inhibitors and cancer stem cell inhibitors

BOSTON BIOMEDICAL INC4 citations83

US9381184B2Jul 5, 2016

Compounds and compositions for targeting cancer stem cells

BOSTON BIOMEDICAL INC4 citations72

US10017488B2Jul 10, 2018

3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof

BOSTON BIOMEDICAL INC2 citations71

US10683274B2Jun 16, 2020

3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof

BOSTON BIOMEDICAL INC1 citations60

US10543189B2Jan 28, 2020

2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer

BOSTON BIOMEDICAL INC1 citations57

LI CHIANG JIA

2 patents

US9084766B2Jul 21, 2015

Compounds and compositions for targeting cancer stem cells

LI CHIANG JIA7 citations83

US9730909B2Aug 15, 2017

Methods for targeting cancer stem cells

LI CHIANG JIA4 citations72

JIANG ZHIWEI

1 patent

US8877803B2Nov 4, 2014

Stat3 pathway inhibitors and cancer stem cell inhibitors

JIANG ZHIWEI13 citations91

SUMITOMO DAINIPPON PHARMA ONCOLOGY INC

1 patent

US10851075B2Dec 1, 2020

Stat3 pathway inhibitors and cancer stem cell inhibitors

SUMITOMO DAINIPPON PHARMA ONCOLOGY INC1 citations72